From “High” ZEB1 to “Low” B-Cell Lymphoma 2-Interacting Mediator of Cell Death (BIM)—an Epithelial-Mesenchymal Transition (EMT)-associated Drug Resistance Pathway Elucidated

Journal of Thoracic Disease - Hong Kong
doi 10.21037/jtd.2018.12.70
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2016English

Knockdown of ZEB1, a Master Epithelial-To-Mesenchymal Transition (EMT) Gene, Suppresses Anchorage-Independent Cell Growth of Lung Cancer Cells

Cancer Letters
Cancer ResearchOncology
2010English

DPY30 Regulates Cervical Squamous Cell Carcinoma by Mediating Epithelial–mesenchymal Transition (EMT)

OncoTargets and Therapy
OncologyPharmacology
2019English

Epithelial-Mesenchymal Transition (EMT) Signature Is Inversely Associated With T-Cell Infiltration in Non-Small Cell Lung Cancer (NSCLC)

Scientific Reports
Multidisciplinary
2018English

“Mesenchymal Stromal Cell Engagement in Cancer Cell Epithelial to Mesenchymal Transition”

Developmental Dynamics
Developmental Biology
2017English

DDB2 Regulates Epithelial-To-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma

Oncotarget
Oncology
2018English

A New Dimension in Drug Discovery: Reversing Epithelial–mesenchymal Transition (EMT)

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2016English

Suppressor of Fused (Sufu) Promotes Epithelial-Mesenchymal Transition (EMT) in Cervical Squamous Cell Carcinoma

Oncotarget
Oncology
2017English

Long Non-Coding RNA ZEB1-AS1 Promotes Cell Invasion and Epithelial to Mesenchymal Transition Through Inducing ZEB1 Expression in Cervical Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy